Tissuemed Profitable

Developer and manufacturer of surgical sealants, Tissuemed has been cash generative for the first time in its history. The accounts for year ended March 31st 2017 show the Leeds-based company profiting from early success in China, together with growth in other targeted international markets.

Audited accounts can be found here.

Chairman Paul Banner, in a letter to shareholders, says; “…the Company is now in a much stronger position than it has ever been. Tissuemed is also in the unique position of having a true surgical sealant product registered for sale in China. In my view, this uniqueness has added a great deal of value to the Company.”